UBS Group AG

Position in IDYA — IDEAYA Biosciences, Inc.

CIK 1610520 ZURICH, V8

Position in IDYA

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$25,408,099

-$12,122,197 QoQ

Shares Held

762,548

-29.8% QoQ

Ownership

0.868%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 95.77154487324077.ToString("F0")% Shared 0.ToString("F0")% None 4.228455126759234.ToString("F0")%

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. IDYA ranks #59 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	22,619,472	$626,559,372
2	PTGX	Protagonist Therapeutics, Inc	5,177,796	$545,739,697
3	ABVX	Abivax S.A.	4,547,406	$506,353,656
4	RVMD	Revolution Medicines, Inc.	4,386,791	$426,615,424
5	INSM	INSMED Inc	1,737,481	$284,112,890
6	VRTX	Vertex Pharmaceuticals Inc / Ma	630,618	$281,596,158
7	APLS	Apellis Pharmaceuticals, Inc.	6,206,681	$249,694,775
8	REGN	Regeneron Pharmaceuticals, Inc.	299,979	$231,775,770

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$25,408,099	762,548	-29.8%	Shares	Defined	2026-05-05
2025-12-31	$37,530,296	1,085,632	+2.7%	Shares	Defined	2026-01-29
2025-09-30	$28,749,459	1,056,577	+40.5%	Shares	Defined	2025-11-13
2025-06-30	$15,805,042	751,905	+67.0%	Shares	Defined	2025-08-14
2025-03-31	$7,373,406	450,147	+7.6%	Shares	Defined	2025-05-13
2024-12-31	$10,755,063	418,485	+199.9%	Shares	Defined	2025-02-14
2024-09-30	$4,420,847	139,547	-39.0%	Shares	Defined	2024-11-14
2024-06-30	$8,033,343	228,805	-5.9%	Shares	Defined	2024-08-14
2024-03-31	$10,664,989	243,049	+61.3%	Shares	Defined	2024-05-13
2023-12-31	$5,361,975	150,702	+166.6%	Shares	Defined	2024-02-09
2023-09-30	$1,525,314	56,535	+524.8%	Shares	Defined	2023-11-09
2023-06-30	$212,651	9,049	-84.0%	Shares	Sole	2023-08-11
2023-03-31	$775,113	56,454	-50.7%	Shares	Sole	2023-05-12
2022-12-31	$2,082,335	114,603	+671.7%	Shares	Sole	2023-02-08
2022-09-30	$221,562	14,850	+222.4%	Shares	Sole	2022-11-10
2022-06-30	$63,562	4,606	-94.0%	Shares	Sole	2022-08-10
2022-03-31	$854,590	76,371	-34.9%	Shares	Defined	2022-05-16
2021-12-31	$2,774,555	117,367	+164.5%	Shares	Defined	2022-02-14
2021-09-30	$1,131,016	44,371	+91.2%	Shares	Defined	2021-11-15
2021-06-30	$487,198	23,211	+87.7%	Shares	Defined	2021-08-13
2021-03-31	$290,577	12,365	+1339.5%	Shares	Defined	2021-05-12
2020-12-31	$12,026	859	+232.9%	Shares	Sole	2021-02-11
2020-09-30	$3,240	258	-93.2%	Shares	Sole	2020-11-12
2020-06-30	$54,211	3,815	+443.4%	Shares	Sole	2020-07-31
2020-03-31	$2,892	702	—	Shares	Sole	2020-05-01
No filing history on record for this holder in this stock.